Luke Clark Selected Research

Gambling (Pathological Gambling)

6/2020	The Conceptual Framework of Harmful Gambling: A revised framework for understanding gambling harm.
1/2019	Interoception and respiratory sinus arrhythmia in gambling disorder.
12/2018	Slot machine gambling and testosterone: Evidence for a "winner-loser" effect?
1/2018	Cognitive distortions and gambling near-misses in Internet Gaming Disorder: A preliminary study.
11/2017	Evidence for GABA-A receptor dysregulation in gambling disorder: correlation with impulsivity.
10/2016	Games in the Brain: Neural Substrates of Gambling Addiction.
6/2016	Down and Out in London: Addictive Behaviors in Homelessness.
5/2016	Increased corticolimbic connectivity in cocaine dependence versus pathological gambling is associated with drug severity and emotion-related impulsivity.
1/2016	Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood.
1/2016	Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luke Clark Research Topics

Disease

23	Gambling (Pathological Gambling) 06/2020 - 11/2009
10	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016 - 01/2003
7	Substance-Related Disorders (Drug Abuse) 01/2016 - 11/2005
3	Opioid-Related Disorders (Opiate Addiction) 11/2017 - 05/2006
3	Cognitive Dysfunction 05/2008 - 08/2003
2	Mental Disorders (Mental Disorder) 12/2021 - 01/2016
2	Cocaine-Related Disorders (Cocaine Addiction) 05/2016 - 11/2012
2	Psychotic Disorders (Schizoaffective Disorder) 11/2013 - 05/2008
2	Alcoholism (Alcohol Abuse) 08/2010 - 11/2009
2	Parkinson Disease (Parkinson's Disease) 12/2007 - 01/2007
2	Mood Disorders (Mood Disorder) 08/2007 - 12/2000
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2015
1	Body Weight (Weight, Body) 11/2013
1	Anxiety Disorders (Anxiety Disorder) 10/2013
1	Dementia (Dementias) 10/2013
1	Tobacco Use Disorder (Nicotine Dependence) 09/2012
1	Frontotemporal Dementia (Semantic Dementia) 03/2006
1	Schizophrenia (Dementia Praecox) 07/2004
1	Mania (Manias) 12/2000

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 11/2017 - 05/2006
7	Methylphenidate (Ritalin)FDA LinkGeneric 04/2009 - 08/2003
6	Dopamine (Intropin)FDA LinkGeneric 01/2013 - 12/2000
5	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016 - 12/2000
4	Cocaine (Cocaine HCl)IBA 01/2016 - 11/2012
3	Modafinil (Provigil)FDA Link 07/2004 - 01/2003
2	Serotonin (5 Hydroxytryptamine)IBA 12/2021 - 08/2007
2	Biological ProductsIBA 06/2020 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 05/2016 - 09/2015
2	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2016 - 11/2007
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 11/2007
1	Nicotine FDA Link 01/2019
1	antineoplaston A10 (A 10)IBA 12/2018
1	Testosterone (Sustanon)FDA Link 12/2018
1	Immunoglobulin D (IgD)IBA 01/2018
1	GABA-A Receptors (GABA(A) Receptor)IBA 11/2017
1	LigandsIBA 11/2017
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 06/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2015
1	LithiumIBA 06/2015
1	Amisulpride (Solian)IBA 11/2013
1	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2013
1	Cholinergic Antagonists (Anticholinergics)IBA 10/2013
1	Antidepressive Agents (Antidepressants)IBA 10/2013
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2013
1	Naltrexone (ReVia)FDA LinkGeneric 01/2013
1	Haloperidol (Haldol)FDA LinkGeneric 01/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013
1	Opioid Analgesics (Opioids)IBA 01/2013
1	Dopamine D2 Receptor AntagonistsIBA 01/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2012
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 11/2007
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 08/2007
1	Levodopa (L Dopa)FDA LinkGeneric 01/2007
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 11/2005
1	Methadone (Dolophine)FDA LinkGeneric 11/2005
1	Heroin (Diamorphine)IBA 11/2005
1	Opiate AlkaloidsIBA 11/2005
1	Guanfacine (Tenex)FDA LinkGeneric 10/2005
1	Nootropic Agents (Nootropics)IBA 07/2004

Therapy/Procedure

3	Therapeutics 12/2007 - 05/2004
1	Aftercare (After-Treatment) 01/2016
1	Traction 01/2013
1	Behavior Control 12/2007
1	Transcranial Magnetic Stimulation 12/2000